<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Neuroepithelial tumor with AAV integration after intracisternal magna vector delivery</title>
  </titleInfo>
  <name type="personal">
    <namePart>Ahrens-Nicklas, Rebecca C.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">Autor</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Kotch, Chelsea</namePart>
  </name>
  <name type="personal">
    <namePart>Roche, Aoife M.</namePart>
  </name>
  <name type="personal">
    <namePart>Everett, John K.</namePart>
  </name>
  <name type="personal">
    <namePart>Reddy, Shantan</namePart>
  </name>
  <name type="personal">
    <namePart>Santi, Mariarita</namePart>
  </name>
  <name type="personal">
    <namePart>Madsen, Peter J.</namePart>
  </name>
  <name type="personal">
    <namePart>Martos-Rus, Cristina</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">pe</placeTerm>
    </place>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
  </language>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>páginas: 2126-2133</extent>
  </physicalDescription>
  <abstract>Recombinant adeno-associated virus (AAV) vectors are predominantly nonintegrating, but rare genomic integration events have been associated with oncogenesis in neonatal murine models. Here we report a case of a neuroepithelial tumor that developed in a 5-year-old boy with severe mucopolysaccharidosis type I (MPSI, Hurler subtype) 4 years after intracisternal magna administration of AAV serotype 9 gene therapy. The patient underwent successful resection of the primary tumor. Postoperatively, he has continued to have advanced cognitive function for his age, a finding that indicates mitigation of MPSI. Molecular analysis of the tumor showed clonal integration of rearranged AAV vector elements into the gene PLAG1 and expression of a chimeric AAV-PLAG1 transcript.</abstract>
  <subject>
    <topic>TUMOR CEREBRAL</topic>
  </subject>
  <subject>
    <topic>ENFERMEDADES INFANTILES</topic>
  </subject>
  <subject>
    <topic>GENÉTICA GENERAL</topic>
  </subject>
  <subject>
    <topic>NEUROLOGÍA</topic>
  </subject>
  <subject>
    <topic>NEUROCIRUGÍA</topic>
  </subject>
  <subject>
    <topic>PEDIATRÍA</topic>
  </subject>
  <relatedItem type="host">
    <titleInfo>
      <title>The New England Journal of Medicine</title>
    </titleInfo>
    <originInfo>
      <publisher>Massachusetts NEJM Group</publisher>
    </originInfo>
    <identifier>NEJM011</identifier>
    <identifier type="issn">0028-4793</identifier>
    <identifier type="local">ESSALUD</identifier>
  </relatedItem>
  <recordInfo>
    <recordContentSource authority="marcorg">BMG</recordContentSource>
    <recordCreationDate encoding="marc">      </recordCreationDate>
    <recordChangeDate encoding="iso8601">20260820162144.0</recordChangeDate>
    <recordIdentifier>ESSALUD</recordIdentifier>
  </recordInfo>
</mods>
